Topical treatment trial after prostate surgery in men
Part of Cancer, Kidney & urinary, Mental health clinical trials.
This Phase 2 study tests how safe and effective a topical medicine (BZ371A) is for men after prostate surgery, with the goal of improving sexual recovery and monitoring side effects. You may be able to join if you meet specific timing, health, and medication criteria after radical prostatectomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man age 40 to 65
- Have had radical prostatectomy (prostate removal) for prostate cancer with no spread (no metastasis), and surgery was under 60 days ago
- Your cancer must not be T3 or T4 stage, and you should not need other prostate cancer treatments like radiation or hormone therapy
- Before surgery, you should have fairly good erections (IIEF score over 22 in domain A)
- You must have stable heterosexual partner plans (together for more than 2 months and willing to stay together during the study)
- You must take tadalafil 5 mg every day from day 30 to day 60 after surgery, and use at least 80% of the pills in that time window
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether daily tadalafil (5 mg) can improve early urinary trouble and erection function after endoscopic prostate tissue removal. It may help men whose urinary symptoms continued even after prior medicine.
This study tests whether a personalized exercise and support program before and after robot-assisted prostate cancer surgery helps men recover better function and quality of life. You'll work with a team to prepare your body before surgery and rebuild strength afterward.
This study tests a program to help men follow sexual (erection) rehabilitation after prostate cancer surgery. It may help improve or maintain erectile functioning by supporting the right rehab steps in the months after surgery.
This trial tests a penile rehabilitation program for men who have nerve-sparing prostate cancer surgery. It aims to help improve erections and sexual function after the procedure.
This study tests whether low-intensity shock wave therapy can help improve erectile function after robotic prostatectomy for low-risk prostate cancer. It is for men who already had fairly good erections before surgery and want to see if this non-invasive treatment can help their recovery.
This Phase 2 study tests whether adding apalutamide to standard hormone therapy (ADT) after prostate surgery can lower the chance that prostate cancer comes back. It targets men at higher risk of recurrence based on PSA levels and a risk score from surgical findings.
Hear when a new Erectile Dysfunction Following Radical Prostatectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.